This Tablet Cures Cancer - Even Multiple Late-stage Cancer Patients Make Dramatic Recoveries
Ivermectin's illustrious history adds weight to its reputation as a significant pharmaceutical discovery. Awarded the Nobel prize in 2015 for its role in combating parasitic diseases like river blindness and lymphatic filariasis, ivermectin has been recognized as one of the most impactful drugs since penicillin. With over 3.7 billion doses administered worldwide, it has contributed immensely to improving human health, particularly in underserved regions. Its success in nearly eradicating river blindness underscores its potential as a low-cost, accessible solution for global health challenges. These credentials bolster its credibility in discussions about repurposing the drug for other medical conditions, including cancer.
Despite its promising safety profile and historical significance, the application of ivermectin in cancer treatment remains controversial and underexplored. Critics argue that anecdotal evidence, while compelling, is not a substitute for rigorous clinical trials. Supporters, including Dr. Ruddy, advocate for deeper investigation into its anti-cancer properties, citing preclinical studies that suggest potential mechanisms, such as inhibiting cancer cell growth and modulating the immune system.